So should NRx Pharmaceuticals (NASDAQ:NRXP) shareholders be worried about its cash burn? In this report, we will consider the company's annual negative free cash flow, henceforth referring to it as ...
NRx Pharmaceuticals, Inc (NASDAQ:NRXP) is among the best psychedelic stocks to buy in 2026. NRx Pharmaceuticals, Inc ...
Detailed price information for Nrx Pharmaceuticals Inc (NRXP-Q) from The Globe and Mail including charting and trades.
Leveraged a partnership with Osmind Inc. to utilize real-world evidence from over 65,000 patients, strengthening the clinical ...
Key highlights for the first full year of operation under the new management team include:A year-over-year reduction in operating expenses with ...
NRx has received confirmatory FDA minutes from in-person Type C meeting attended by leadership of FDA Division of Psychiatry, FDA Office of ...
Determination of bioequivalence to the Reference Listed Drug is essential for approval of an Abbreviated New Drug Application ...
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
NRx Pharmaceuticals (NASDAQ:NRXP – Get Free Report)‘s stock had its “buy” rating reaffirmed by D. Boral Capital in a research report issued to clients and investors on Monday,Benzinga reports. They ...
As of Monday, March 16, NRx Pharmaceuticals, Inc.’s NRXP share price has surged by 13.44%, which has investors questioning if ...
NRx Pharmaceuticals may have validated a new manufacturing process, but that doesn't mean the FDA finds it valid. Last week, NRX Pharmaceuticals stock nearly tripled in response to a positive clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results